Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$12.52 - $20.5 $79,226 - $129,724
6,328 New
6,328 $124,000
Q4 2021

Feb 14, 2022

SELL
$14.55 - $18.6 $12,207 - $15,605
-839 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$15.44 - $17.77 $1,821 - $2,096
118 Added 16.37%
839 $13,000
Q2 2021

Aug 13, 2021

SELL
$16.58 - $19.0 $227,295 - $260,471
-13,709 Reduced 95.0%
721 $13,000
Q1 2021

May 13, 2021

BUY
$17.74 - $20.35 $57,406 - $65,852
3,236 Added 28.91%
14,430 $262,000
Q4 2020

Feb 11, 2021

BUY
$17.06 - $22.15 $11,634 - $15,106
682 Added 6.49%
11,194 $194,000
Q3 2020

Nov 12, 2020

SELL
$20.71 - $26.49 $61,467 - $78,622
-2,968 Reduced 22.02%
10,512 $220,000
Q2 2020

Aug 12, 2020

BUY
$14.18 - $25.49 $191,146 - $343,605
13,480 New
13,480 $288,000
Q1 2020

May 13, 2020

SELL
$11.21 - $21.54 $65,040 - $124,975
-5,802 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$19.23 - $20.78 $115 - $124
-6 Reduced 0.1%
5,802 $114,000
Q3 2019

Nov 14, 2019

SELL
$20.51 - $25.07 $288,247 - $352,333
-14,054 Reduced 70.76%
5,808 $120,000
Q2 2019

Aug 14, 2019

BUY
$19.2 - $22.8 $342,969 - $407,276
17,863 Added 893.6%
19,862 $427,000
Q1 2019

May 15, 2019

BUY
$20.07 - $23.69 $37,651 - $44,442
1,876 Added 1525.2%
1,999 $41,000
Q4 2018

Feb 14, 2019

SELL
$20.07 - $25.33 $46,341 - $58,486
-2,309 Reduced 94.94%
123 $2,000
Q3 2018

Nov 14, 2018

BUY
$23.9 - $28.4 $47,369 - $56,288
1,982 Added 440.44%
2,432 $60,000
Q2 2018

Aug 14, 2018

SELL
$26.08 - $29.8 $21,933 - $25,061
-841 Reduced 65.14%
450 $12,000
Q1 2018

May 15, 2018

BUY
$22.95 - $29.8 $6,563 - $8,522
286 Added 28.46%
1,291 $38,000
Q4 2017

Feb 14, 2018

SELL
$22.55 - $33.6 $66,206 - $98,649
-2,936 Reduced 74.5%
1,005 $25,000
Q3 2017

Nov 14, 2017

BUY
$26.05 - $30.75 $102,663 - $121,185
3,941
3,941 $120,000

Others Institutions Holding FONR

About FONAR CORP


  • Ticker FONR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 6,554,210
  • Market Cap $116M
  • Description
  • FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic servi...
More about FONR
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.